The IPC Evidence Base for Reusable Cloth Surgical Caps vs Disposable Bouffant Headwear: A Verification Report for NHS IPC Teams and Procurement Leads

TL;DR

• The peer-reviewed IPC evidence does NOT support mandating disposable-only headwear: the consistent, repeatedly replicated finding across observational studies and the largest meta-analysis (Gumera 2024, 45,708 cases, OR 0.79, 95% CI 0.59–1.07, P=0.13) is "no significant difference" in surgical site infection (SSI) rates between reusable cloth and disposable headwear.
• Eight of the nine cited studies verified accurately, but TWO factual errors must be fixed before publication: the "Hussain et al., Neurosurgery 2018" study is actually Shallwani H et al. (the first author's given name is Hussain), and the background claim that staff "shed roughly 200 million skin cells an hour, ~10% carrying bacteria" is NOT supported by the primary literature, which states ~10 million (10⁷) skin particles dispersed per day, ~10% carrying viable bacteria.
• The honest position for NHS teams: cloth caps are at least as safe as disposables for infection outcomes and have a clear environmental/cost advantage, BUT hygiene depends entirely on laundering — the 2026 Hughes study found higher bacterial loads on cloth caps in uncontrolled everyday use, so the defensible policy is robust, auditable laundering standards, not a material ban.

Key Findings

Verification status of the nine cited studies

All nine studies exist and were located in peer-reviewed sources. Eight had their key figures confirmed as accurate. The "Hussain et al." attribution is a naming error (the author is Hussain Shallwani, conventionally cited as Shallwani H). The standalone "200 million skin cells per hour" claim could not be verified and conflicts with the primary source.

The evidence does not support disposable-only mandates

Multiple large observational analyses (Shallwani 2018, n>15,000; Kothari 2018, n=1,543; Haskins 2017) and two real-world policy analyses (Elmously 2019; Farach 2018) found no SSI benefit from disposable bouffant mandates. The Gumera 2024 meta-analysis is the strongest synthesis and confirms equivalence with an environmental advantage for reusables. National and international guidance bodies (NICE NG125, WHO 2018) make no recommendation on cap type at all.

The genuine caution: laundering, not material

The 2026 Hughes study is the most important counter-weight and must be represented fairly. It found cloth caps carried significantly more bacteria than disposables in everyday (uncontrolled-laundering) use. The authors' own conclusion was that the answer is proper sterilisation/laundering of cloth caps, not abandoning them.

Details

1. Markel et al. (2017) — "Hats Off" — VERIFIED. Markel TA, Gormley T, Greeley D, et al. "Hats Off: A Study of Different Operating Room Headgear Assessed by Environmental Quality Indicators." Journal of the American College of Surgeons 2017;225(5):573–581. DOI: 10.1016/j.jamcollsurg.2017.08.014. PMID 29106842. Mock-surgery study in a dynamic OR environment. Key finding confirmed verbatim: "When compared with cloth skull caps, disposable bouffants yielded greater permeability, greater particulate contamination, and greater passive microbial shed. Disposable style bouffant hats should not be considered superior to skull caps." Bouffants had higher 0.5µm and 1.0µm particle levels, larger average and maximum pore sizes, and were significantly more permeable than either disposable or cloth skull caps. Funded by ACS and ASA. Important nuance: between disposable bouffant and disposable skull caps there was no significant difference on actively-sampled microbial/particle contamination; the cloth advantage was specifically on permeability, particulates and passive settle-plate microbial shed. The study measured environmental quality indicators, not patient SSI outcomes.

2. Haskins et al. (2017) — VERIFIED. Haskins IN, Prabhu AS, Krpata DM, et al. "Is there an association between surgeon hat type and 30-day wound events following ventral hernia repair?" Hernia 2017;21(4):495–503. DOI: 10.1007/s10029-017-1626-7. PMID 28631104. Used the Americas Hernia Society Quality Collaborative (AHSQC) database; surgeons (≥10 patients each with 30-day follow-up) were surveyed on the type of surgical hat they wear; association with 30-day wound events tested by multivariate logistic regression. Finding confirmed: no association between any type of surgical hat worn and the incidence of postoperative wound events. (This was a ventral hernia repair database study, as the user surmised.)

3. "Hussain et al." Neurosurgery 2018 — CITATION ERROR; CONTENT VERIFIED. The correct citation is Shallwani H, Shakir HJ, Aldridge AM, Donovan MT, Levy EI, Gibbons KJ. "Mandatory Change From Surgical Skull Caps to Bouffant Caps Among Operating Room Personnel Does Not Reduce Surgical Site Infections in Class I Surgical Cases: A Single-Center Experience With More Than 15,000 Patients." Neurosurgery 2018;82(4):548–554. DOI: 10.1093/neuros/nyx211. PMID 29447369. The first author's given name is Hussain, which is the source of the error. Finding confirmed: SSI rates compared 13 months before (7,513 patients) and after (8,446 patients) a mandatory switch to bouffant caps at a single 25-OR site; cumulative SSI rate rose 0.07% (0.77%→0.84%) for all Class I cases and 0.03% (0.79%→0.82%) for spinal procedures — neither statistically significant (P>0.05). I.e., switching from skull caps to bouffants did not reduce SSIs.

4. Kothari et al. (2018) — VERIFIED. Kothari SN, Anderson MJ, Borgert AJ, Kallies KJ, Kowalski TJ. "Bang Your Head — Bouffant vs Skull Caps and Impact on Surgical Site Infections: Does it Really Matter?" (published as "Bouffant vs Skull Cap and Impact on Surgical Site Infection: Does Operating Room Headwear Really Matter?") Journal of the American College of Surgeons 2018;227(2):198–202. DOI: 10.1016/j.jamcollsurg.2018.04.029. PMID 29733905. Re-analysis of a prior prospective randomised hair-clipping trial. 1,543 patients; attending surgeons wore bouffant caps in 39% and skull caps in 61%. Raw SSI rates 8% (bouffant) vs 5% (skull cap) confirmed (6% vs 4% superficial; 0.8% vs 0.2% deep). After accounting for surgical procedure type, no significant difference remained. All figures confirmed exactly.

5. Nyima et al. (2024) — VERIFIED; JOURNAL FLAGGED AS LOW-AUTHORITY. Nyima T, Rafteseth S, Gardner J, Mitchell A. "Disposable Bouffant Caps Vs Cloth Surgical Caps." Surgical Research (Surg Res) 2024;6(1):1–9. DOI: 10.33425/2689-1093.1066. The journal name "Surgical Research" is complete but refers to a SciVision Publishers title — a low-profile, non-PubMed-indexed journal; this should be flagged as lower-authority evidence. Finding confirmed: this rapid review (sources 2017–2023) found no conclusive evidence that disposable over cloth caps changes SSI incidence, and that cloth caps/skullcaps improve team communication and reduce carbon footprint and cost.

6. Gumera et al. (2024) — KEY STUDY — ALL FIGURES VERIFIED. Gumera A, Mil M, Hains L, Fanshaw S-R, Dunne B. "Reusable surgical headwear has a reduced carbon footprint and matches disposables regarding surgical site infection: a systematic review and meta-analysis." Journal of Hospital Infection 2024;152:164–172. DOI: 10.1016/j.jhin.2024.07.017. PMID 39197751. Confirmed published by Elsevier on behalf of The Healthcare Infection Society (HIS) — i.e. yes, this is the flagship HIS journal. Systematic review included nine studies; the meta-analysis included six studies involving 45,708 procedural cases. No significant difference in SSI between reusable and disposable groups: OR 0.79; 95% CI 0.59–1.07; P=0.13 — confirmed exactly. Policy-implementation analysis: OR 1.21; 95% CI 0.85–1.73; P=0.30 — confirmed exactly. Reusables had a significantly lower carbon footprint (P<0.001) — the paper quantifies this as a reduction of 11 kg CO₂ equivalents per reusable-headwear policy — plus significantly lower ozone depletion, fossil-fuel depletion, terrestrial acidification, and fine particulate matter formation (all P<0.005). Risk of bias assessed with ROBINS-I; aggregation in RevMan 5.4. Interpretation note: the OR<1 favours reusables numerically, but the confidence interval crosses 1, so the correct reading is equivalence, not cloth superiority for infection.

7. Hughes et al. (2026) — VERIFIED (full text). Hughes J, Pilc EM, Bridges C, Tuten HR. "Surgeons' personal cloth scrub caps: harmless perk or implicit infection prevention risk?" Patient Safety in Surgery 2026;20:2. DOI: 10.1186/s13037-025-00465-9. Published 29 January 2026; Bon Secours, Richmond, VA. Prospective cohort at a 391-bed US medical centre; 107 caps sampled (58 cloth, 49 disposable paper) from surgeons, PAs, NPs, surgical assistants and scrub nurses; cultured 3 days on blood agar. Mean CFU: cloth 5.16 (SD 11.78) vs paper 1.06 (SD 3.60); mean growth rank cloth 0.93 (SD 0.99) vs paper 0.20 (SD 0.61); both P<0.001 (Mann–Whitney U). All figures confirmed exactly. Verbatim abstract conclusion: "Attention should be given to the proper sterilization of cloth scrub caps in order to decrease the infectious load on items in the operating room." Crucially, the authors state in the discussion: "our study did not select for the laundering status of cloth caps, which suggests that cap material is not the driving factor in the caps' bacterial loads." Authors' acknowledged limitations: caps were measured for colonisation, NOT actual patient SSI outcomes; disposable caps were swabbed pristine straight from the box while cloth caps were in real-world used state (an asymmetry the authors flag); only a single S. aureus colony was found, with the vast majority of growth being coagulase-negative staphylococci.

8. Bartek et al. (2017) and Hill et al. (1974) — VERIFIED. Bartek M, Verdial F, Dellinger EP. "Naked Surgeons? The Debate About What to Wear in the Operating Room." Clinical Infectious Diseases 2017;65(9):1589–1592. DOI: 10.1093/cid/cix498. A non-systematic literature review; key stated conclusion: "There is no evidence regarding SSI risk related to operating room attire except for sterile gowns and the use of gloves," and that naked surgeons shed fewer bacteria into the OR environment than those wearing scrub suits. The underlying dispersal science traces to Hill J, Howell A, Blowers R. "Effect of clothing on dispersal of Staphylococcus aureus by males and females." Lancet 1974;2(7889):1131–1133 (PMID 4139421), verbatim: "Dispersal of Staphylococcus aureus into the air is fairly common and is sometimes profuse among men, but is rare and very slight among young women. Shedding from the skin is increased by friction from clothes." Companion paper: Mitchell NJ, Gamble DR, "Clothing design for operating room personnel," Lancet 1974;2:1133–1136. Together these established that fabric friction releases bacteria-laden skin scales and that weave density/fit affect how many become airborne — supporting the article's claim, with the caveat that this is dispersal science, not SSI-outcome evidence.

9. O'Connor et al. (2026) — VERIFIED. O'Connor KP, Stegelmann SD, Drawbert H, Dudoussat E, Riehl JT. "Facial Hair and Its Influence on Surgical Site Infection: A Systematic Review to Address a Bald Spot in the Literature." Orthopaedic Nursing 2026;45(2):107–114. PRISMA review; 538 studies screened, 8 met inclusion (confirmed exactly). Finding confirmed: clinical studies showed no statistically significant difference in SSI rates between uncovered bearded, uncovered clean-shaven, or beard-covered surgeons; laboratory studies gave mixed results on bacterial shedding; a consensus statement found insufficient evidence to recommend beard covers; overall evidence graded equivocal/insufficient to justify routine beard covers.

Background claim — "200 million skin cells an hour, ~10% bacteria-carrying" — PARTIALLY INACCURATE; CORRECT BEFORE PUBLICATION. The authoritative primary figure (Larson E, CDC/Emerging Infectious Diseases 2001;7(2), "Hygiene of the Skin: When Is Clean Too Clean?") states: "From healthy skin, approximately 10⁷ [10 million] particles are disseminated into the air each day, and 10% of these skin squames contain viable bacteria." The "~10% carry viable bacteria" portion is well-supported. The "200 million per hour" figure is NOT found in the primary literature and appears to be a vendor-blog amplification. The total-skin-turnover context is distinct: the stratum corneum is "completely replaced every 2 weeks; a new layer is formed approximately daily" (same CDC source) — this should not be conflated with the ~10⁷/day airborne-particle figure. NHS teams should use the conservative, sourced version (~10 million skin particles dispersed into air per day, ~10% bacteria-carrying) and drop the "200 million per hour" claim.

UK and international guidance

NHS England, "Uniforms and workwear: guidance for NHS employers" (published 2 April 2020) — VERIFIED; still current. This remains the current version as of June 2026 (no superseding 2022–2026 edition was found; it draws on the 2007 evidence base, two Thames Valley University literature reviews, and UCLH laundering research). Confirmed claims, quoted: "washing with detergents at 30ºC will remove most Gram-positive micro-organisms, including methicillin-resistant Staphylococcus aureus (MRSA)"; "a ten minute wash at 60ºC is sufficient to remove almost all micro-organisms. In tests, only 0.1% of any Clostridioides difficile spores remained. Microbiologists carrying out the research advise that this level of contamination on uniforms and workwear is not a cause for concern"; and "there is little effective difference between domestic and commercial laundering in terms of removing micro-organisms," which legitimises home laundering at 60ºC. Important scope note: this guidance addresses uniforms/workwear generally, not theatre caps specifically, and does not mandate any cap type. The separate NHS England National IPC Manual (NIPCM) for England and HTM 01-04 govern healthcare-laundered theatre linen.

NICE NG125 "Surgical site infections: prevention and treatment" — VERIFIED; SILENT on cap type. Published 11 April 2019, last updated 19 August 2020, last reviewed 31 May 2023 (NICE confirmed an update "will not proceed as planned"). NG125 recommends that "all staff should wear specific non-sterile theatre wear in all areas where operations are undertaken" [2008] and that staff "keep their movements in and out of the operating area to a minimum" [2008], but it makes NO recommendation on bouffant vs skull cap or reusable vs disposable headwear. The cap controversy is simply not addressed — an evidence gap NHS teams should note explicitly.

WHO Global Guidelines for the Prevention of Surgical Site Infection (2016; 2nd ed. 2018) — VERIFIED; NO headwear recommendation. WHO issued 29 recommendations across 23 topics; surgical headwear/head-covering type is NOT among them (for four topics WHO judged the evidence insufficient to develop a recommendation). WHO likewise made no recommendation on disposable vs reusable drapes/gowns ("No recommendation is available on the use of disposable or reusable drapes and gowns"). WHO DOES recommend on hair removal: "In patients undergoing any surgical procedure, hair either should not be removed or, if removal is absolutely necessary, should be removed only with a clipper. Shaving is strongly discouraged at all times, whether preoperatively or in the OR" (supporting meta-analysis OR 0.51; 95% CI 0.34–0.78 favouring clipping/no removal over shaving). The absence of a WHO headwear recommendation is itself meaningful: the global evidence review did not find a basis to mandate any particular head covering.

AfPP (Association for Perioperative Practice). AfPP's benchmark "Standards and Recommendations for Safe Perioperative Practice" (5th edition, 2022 — confirmed current via afpp.org.uk) is the principal UK perioperative reference. AfPP's position is that the purpose of headwear is to cover all hair to prevent contamination of wounds from hair/dandruff falling from heads, beards or moustaches, and that theatre attire should be close-knit, antistatic, lint-free material. AfPP requires hair coverage but does not mandate disposable over reusable caps.

AORN 2014–2019 reversal — VERIFIED; central IPC context. In 2014/2015 AORN's "Guideline for Surgical Attire" recommended bouffant hats covering all hair, scalp and ears, producing a de facto prohibition on skull caps that CMS and The Joint Commission enforced (e.g., Kaleida Health received an "immediate jeopardy" letter). Following the Markel study and mounting criticism, a February 2018 multi-society summit (ACS, AORN, ASA, APIC, AST, the Council on Surgical and Perioperative Safety, and The Joint Commission) concluded "the requirement for ear coverage is not supported by sufficient evidence" and that "at present, available scientific evidence does not demonstrate any association between the type of hat or extent of hair coverage and SSI rates." AORN revised its guideline (public comment Jan–Feb 2019; published 2019) to make no recommendation on head-cover type and to drop the ear-coverage mandate. This is the cautionary tale at the heart of the debate: an evidence-light, disposable-favouring guideline was implemented top-down, then walked back.

Counter-evidence (for balance)

Two strands favour disposables and must be represented fairly. First, the Hughes 2026 cap-level colonisation study (detailed above) — the strongest direct caution. Second, clean-air-suit studies: Tammelin A, Kylmänen P, Samuelsson A, J Hosp Infect 2023;135:119–124 (PMID 36963617) found, in a turbulent-mixing-ventilation room, mean airborne counts of 1.3–10.8 CFU/m³ with reusable mixed-material scrubs vs 0.8–4.0 CFU/m³ with single-use polypropylene scrubs (P<0.01); an earlier Tammelin study (J Hosp Infect 2013, PMID 23694760) reached the same conclusion. However, these concern full-body clothing systems, not caps, and measure air CFU not SSI outcomes; their relevance to the cap-specific question is indirect. No study was found showing disposable caps reduce actual SSI rates versus cloth caps. (Note also a vendor-circulated claim that SSIs fell 5.1%→2.6% when a hospital switched to reusables during COVID; this is a confounded single-centre observation and should not be cited as causal evidence for cloth superiority.)

Recommendations

Stage 1 — Fix the article's factual errors before publication. (a) Correct "Hussain et al." to "Shallwani H et al." (Neurosurgery 2018;82(4):548–554; DOI 10.1093/neuros/nyx211). (b) Replace the "200 million skin cells an hour, ~10% bacteria-carrying" claim with the sourced figure: ~10 million (10⁷) skin particles dispersed into the air per day, ~10% carrying viable bacteria (Larson, CDC/Emerg Infect Dis 2001) — or drop the per-hour figure entirely. (c) Flag Nyima et al. as published in a low-profile, non-indexed journal and lead instead with Gumera (HIS/Journal of Hospital Infection) as the headline synthesis. (d) Add DOIs/PMIDs (provided above) so every figure can be independently checked.

Stage 2 — Frame the claim defensibly. State the evidence as "no significant difference in SSI (statistical equivalence), plus a clear environmental and cost advantage for reusables," NOT "cloth caps are safer for infection." Make explicit that (i) the Markel particle-shedding advantage was measured in mock surgery, not patient outcomes; (ii) the Gumera OR of 0.79 still has a CI crossing 1; and (iii) guidance bodies (NICE, WHO) make no recommendation on cap type.

Stage 3 — Make laundering the policy centrepiece. Recommend NHS teams pair any reusable-cap adoption with an auditable laundering standard: ≥60°C wash after each shift/case in high-risk areas (theatres/ICUs), multiple caps per staff member so a clean one is always available, segregation of clean/dirty caps in a dedicated bag, and a defined route (home laundering at 60°C is legitimate per NHS England 2020, or hospital laundry per HTM 01-04). Cite the Hughes 2026 caution as the rationale and recommend a local audit of laundering compliance as the genuine determinant of cloth-cap hygiene.

Benchmarks that would change the recommendation: A well-conducted RCT or large prospective cohort showing either (a) a statistically significant SSI difference by cap material, or (b) that real-world laundering compliance cannot be reliably achieved in a given unit, would shift the balance toward caution. Absent either, disposable-only mandates remain unsupported by infection-control evidence — and carry an avoidable environmental and cost penalty.

Caveats

• The dominant finding is "no significant difference," NOT demonstrated cloth superiority for infection outcomes. The article and PDF briefing must not overstate this.
• Most evidence is observational (database/registry analyses, mock-surgery and air-sampling studies); there is no large RCT of cap material with SSI as the primary endpoint. Overall confidence is therefore moderate.
• Cap-level colonisation studies (Hughes 2026) show poorly laundered cloth caps genuinely can carry higher bacterial loads; the cloth advantage is strictly conditional on laundering compliance, and Hughes measured colonisation rather than patient SSI.
• Several cited items are non-UK (US AORN/ACS/Kothari/Shallwani/Hughes data; Australian Gumera meta-analysis). Applicability to UK theatres is reasonable but not direct; the genuinely UK-authoritative anchors are NHS England 2020, NICE NG125, AfPP 2022 and the Hill/Lancet 1974 dispersal science.
• Two weak links are flagged: Nyima et al. is in a low-authority journal, and the "200 million cells/hour" figure originates from vendor marketing rather than primary science.
• Guidance bodies (NICE, WHO) are silent on cap type, which cuts both ways: it does not endorse cloth caps, but it equally removes any basis for a disposable-only mandate.